UNSPSC 51422417: Hydrocortisone butyrate

This classification denotes a therapeutic glucocorticoid with the molecular formula C25H36O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 05RMF7YPWN, chemically known as 11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione but generally known as hydrocortisone butyrate, which bears US NIH Compound Identifier 5754. European Medicines Agency schedules Hydrocortisone butyrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02563MIG.

UNSPSC 51422417 Hydrocortisone butyrate is a Commodity code that nominally covers a specific corticosteroid pharmaceutical product, yet the single recent state-local opportunity posted under this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and drug deactivation systems rather than hydrocortisone butyrate. This mismatch signals either a coding error in the county's procurement system or material divergence between the UNSPSC taxonomy and actual state-local spend under this code. The opportunity itself targets public health initiatives, requiring annual delivery of 1,900 units of naloxone and 800 safe drug deactivation systems on a quarterly basis to the Seminole County Community Health Building. Bidders must cover all shipping and delivery costs, maintain workers' compensation and general liability insurance, comply with E-Verify requirements, and meet FEMA compliance standards including Clean Air Act and Federal Water Pollution Control Act adherence. The contract runs for an initial two-year term with an optional one-year renewal and includes a three-month probationary termination clause.

Seminole County is the only issuing body represented in recent opportunities under this code. The procurement was posted June 30, 2026, with a response deadline of July 26, 2023—a date that appears to contain a data quality issue and may reflect system archival or mismatched records. No other state, county, city, school district, or transit authority opportunities are visible in the recent activity block. The code shows minimal recent state-local solicitation volume, and the one opportunity on record does not align with the pharmaceutical product nominally defined by the code, raising questions about whether this Commodity code is actively used by state and local buyers for its stated purpose.